Search by Drug Name or NDC

    NDC 72606-0011-01 Vegzelma 100 mg/4mL Details

    Vegzelma 100 mg/4mL

    Vegzelma is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CELLTRION USA, Inc.. The primary component is BEVACIZUMAB.

    Product Information

    NDC 72606-0011
    Product ID 72606-011_d58b28c8-9a47-4869-92c5-a55895ec1605
    Associated GPIs
    GCN Sequence Number 083878
    GCN Sequence Number Description bevacizumab-adcd VIAL 25 MG/ML INTRAVEN
    HIC3 V1X
    HIC3 Description ANTINEOPLAST HUM VEGF INHIBITOR RECOMB MC ANTIBODY
    GCN 52948
    HICL Sequence Number 048357
    HICL Sequence Number Description BEVACIZUMAB-ADCD
    Brand/Generic Brand
    Proprietary Name Vegzelma
    Proprietary Name Suffix n/a
    Non-Proprietary Name bevacizumab-adcd
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/4mL
    Substance Name BEVACIZUMAB
    Labeler Name CELLTRION USA, Inc.
    Pharmaceutical Class Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761268
    Listing Certified Through 2024-12-31

    Package

    NDC 72606-0011-01 (72606001101)

    NDC Package Code 72606-011-01
    Billing NDC 72606001101
    Package 1 VIAL, SINGLE-USE in 1 CARTON (72606-011-01) / 4 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2023-04-03
    NDC Exclude Flag N
    Pricing Information N/A